Company Filing History:
Years Active: 2000-2009
Title: Innovations of Jennifer T Jones
Introduction
Jennifer T Jones is an accomplished inventor based in San Leandro, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of heregulin variants. With a total of 4 patents to her name, her work has the potential to impact therapeutic approaches in cancer treatment.
Latest Patents
One of her latest patents focuses on heregulin variants that are capable of binding to ErbB receptors. This invention includes variants of human heregulins, specifically variants of human heregulin-β1 that exhibit enhanced affinity for the ErbB-3 and ErbB-4 receptors. These variants consist of at least one amino acid substitution and may include additional modifications. Furthermore, the invention encompasses nucleic acid molecules encoding these heregulin variants, along with related vectors, host cells, pharmaceutical compositions, and methods.
Career Highlights
Jennifer T Jones is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. Her work at Genentech has allowed her to collaborate with other talented professionals in the field.
Collaborations
Some of her notable coworkers include Marcus D Ballinger and Wayne J Fairbrother, who contribute to the collaborative environment that fosters innovation and research excellence.
Conclusion
Jennifer T Jones is a prominent inventor whose work on heregulin variants showcases her expertise and dedication to advancing biotechnology. Her contributions have the potential to lead to significant advancements in medical treatments.